https://vasas.ch/en/ https://vasas.ch/en/about-vasas https://vasas.ch/en/about-us https://vasas.ch/en/affected-persons https://vasas.ch/en/specialists https://vasas.ch/en/vasas-research-grant https://vasas.ch/en/clinical-pictures https://vasas.ch/en/current https://vasas.ch/en/events https://vasas.ch/en/event-details https://vasas.ch/en/news https://vasas.ch/en/news-article https://vasas.ch/en/current/studies https://vasas.ch/en/current/studies/studies-details https://vasas.ch/en/become-active https://vasas.ch/en/contact-us https://vasas.ch/en/donations https://vasas.ch/en/become-a-member https://vasas.ch/en/members https://vasas.ch/en/search https://vasas.ch/en/privacy-policy https://vasas.ch/en/imprint https://vasas.ch/fr/ https://vasas.ch/fr/a-propos-de-vasas https://vasas.ch/fr/a-propos-de-nous https://vasas.ch/fr/personnes-concernees https://vasas.ch/fr/specialistes https://vasas.ch/fr/demandes-de-subvention-aupres-de-vasas https://vasas.ch/fr/tableaux-cliniques https://vasas.ch/fr/actuel https://vasas.ch/fr/evenements https://vasas.ch/fr/details-de-l-evenement https://vasas.ch/fr/actualites https://vasas.ch/fr/articles-de-presse https://vasas.ch/fr/actuel/l-etude https://vasas.ch/fr/actuel/l-etude/details-des-etudes https://vasas.ch/fr/devenir-actif https://vasas.ch/fr/contact https://vasas.ch/fr/dons https://vasas.ch/fr/devenir-membre https://vasas.ch/fr/membres https://vasas.ch/fr/recherche https://vasas.ch/fr/declaration-de-confidentialite https://vasas.ch/fr/mentions-legales https://vasas.ch/de/ https://vasas.ch/de/ueber-vasas https://vasas.ch/de/ueber-uns https://vasas.ch/de/betroffene https://vasas.ch/de/fachpersonen https://vasas.ch/de/foerderantraege-bei-vasas https://vasas.ch/de/krankheitsbilder https://vasas.ch/de/aktuell https://vasas.ch/de/events https://vasas.ch/de/event-details https://vasas.ch/de/news https://vasas.ch/de/newsartikel https://vasas.ch/de/studien https://vasas.ch/de/studien-details https://vasas.ch/de/aktiv-werden https://vasas.ch/de/kontakt https://vasas.ch/de/spenden https://vasas.ch/de/mitglied-werden https://vasas.ch/de/mitglieder https://vasas.ch/de/suche https://vasas.ch/de/datenschutzerklaerung https://vasas.ch/de/impressum https://vasas.ch/de/newsartikel/secukinumab-in-pmr https://vasas.ch/de/newsartikel/real-world-safety-assessment-of-avacopan-in-patients-with-antineutrophil-cytoplasmic-antibody-associated-vasculitis https://vasas.ch/de/newsartikel/safety-of-avacopan-for-the-treatment-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-combined-data-from-three-clinical-trials https://vasas.ch/de/newsartikel/einreichung-von-foerderantraegen https://vasas.ch/de/newsartikel/baricitinib-in-early-polymyalgia-rheumatica-bachelor-a-randomised-double-blind-placebo-controlled-parallel-group-trial https://vasas.ch/de/newsartikel/normal-inflammatory-markers-in-giant-cell-arteritis-a-diagnostic-blind-spot-1 https://vasas.ch/de/newsartikel/suche-nach-egpa-patienten-in-ch-de-en-fr https://vasas.ch/de/newsartikel/treatment-efficacy-and-safety-of-adalimumab-versus-tocilizumab-in-patients-with-active-and-severe-takayasu-arteritis-an-open-label-study https://vasas.ch/de/newsartikel/A-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis https://vasas.ch/de/newsartikel/maintenance-of-remission-of-anca-vasculitis-by-rituximab-based-on-b-cell-repopulation-versus-serological-flare-a-randomised-trial https://vasas.ch/de/newsartikel/development-of-a-diagnostic-prediction-model-for-giant-cell-arteritis https://vasas.ch/de/newsartikel/distinct-pulmonary-patterns-in-anca-associated-vasculitides https://vasas.ch/de/newsartikel/c1q-deficiency-cns-inflammation https://vasas.ch/en/news-article/secukinumab-in-patients-with-polymyalgia-rheumatica-week-52-results-of-a-phase-3-multicentre-randomized-double-blind-placebo-controlled-trial-replenish https://vasas.ch/en/news-article/real-world-safety-assessment-of-avacopan-in-patients-with-antineutrophil-cytoplasmic-antibody-associated-vasculitis-2 https://vasas.ch/en/news-article/safety-of-avacopan-for-the-treatment-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-combined-data-from-three-clinical-trials-2 https://vasas.ch/en/news-article/baricitinib-in-early-polymyalgia-rheumatica-bachelor-a-randomised-double-blind-placebo-controlled-parallel-group-trial-kopie https://vasas.ch/en/news-article/normal-inflammatory-markers-in-giant-cell-arteritis-a-diagnostic-blind-spot https://vasas.ch/en/news-article/search-for-egpa-patients-in-ch-de-en-fr https://vasas.ch/en/news-article/treatment-efficacy-and-safety-of-adalimumab-versus-tocilizumab-in-patients-with-active-and-severe-takayasu-arteritis-an-open-label-study-2 https://vasas.ch/en/news-article/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis https://vasas.ch/en/news-article/maintenance-of-remission-of-anca-vasculitis-by-rituximab-based-on-b-cell-repopulation-versus-serological-flare-a-randomised-trial-2 https://vasas.ch/en/news-article/development-of-a-diagnostic-prediction-model-for-giant-cell-arteritis-by-sequential-application-of-southend-giant-cell-arteritis-probability-score-and-ultrasonography-a-prospective-multicentre-study https://vasas.ch/en/news-article/distinct-pulmonary-patterns-in-anca-associated-vasculitides-insights-from-a-retrospective-single-center-cohort-study-1 https://vasas.ch/en/news-article/hereditary-c1q-deficiency-is-associated-with-type-1-interferon-pathway-activation-and-a-high-risk-of-central-nervous-system-inflammation https://vasas.ch/fr/articles-de-presse/secukinumab-in-patients-with-polymyalgia-rheumatica-week-52-results-of-a-phase-3-multicentre-randomized-double-blind-placebo-controlled-trial-replenish-2 https://vasas.ch/fr/articles-de-presse/real-world-safety-assessment-of-avacopan-in-patients-with-antineutrophil-cytoplasmic-antibody-associated-vasculitis-3 https://vasas.ch/fr/articles-de-presse/safety-of-avacopan-for-the-treatment-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-combined-data-from-three-clinical-trials-3 https://vasas.ch/fr/articles-de-presse/baricitinib-in-early-polymyalgia-rheumatica-bachelor-a-randomised-double-blind-placebo-controlled-parallel-group-trial-kopie-2 https://vasas.ch/fr/articles-de-presse/normal-inflammatory-markers-in-giant-cell-arteritis-a-diagnostic-blind-spot-2 https://vasas.ch/fr/articles-de-presse/recherche-de-patients-egpa-en-ch-de-en-fr https://vasas.ch/fr/articles-de-presse/treatment-efficacy-and-safety-of-adalimumab-versus-tocilizumab-in-patients-with-active-and-severe-takayasu-arteritis-an-open-label-study-3 https://vasas.ch/fr/articles-de-presse/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis-2 https://vasas.ch/fr/articles-de-presse/maintenance-of-remission-of-anca-vasculitis-by-rituximab-based-on-b-cell-repopulation-versus-serological-flare-a-randomised-trial-3 https://vasas.ch/fr/articles-de-presse/development-of-a-diagnostic-prediction-model-for-giant-cell-arteritis-by-sequential-application-of-southend-giant-cell-arteritis-probability-score-and-ultrasonography-a-prospective-multicentre-study-2 https://vasas.ch/fr/articles-de-presse/distinct-pulmonary-patterns-in-anca-associated-vasculitides-insights-from-a-retrospective-single-center-cohort-study-1-2 https://vasas.ch/fr/articles-de-presse/hereditary-c1q-deficiency-is-associated-with-type-1-interferon-pathway-activation-and-a-high-risk-of-central-nervous-system-inflammation-2 https://vasas.ch/de/studien-details/pet-diagnostikstudie https://vasas.ch/de/studien-details/takayasuarteritis-clinical-imaging-molecular-and-therapeutic-characteristics https://vasas.ch/de/studien-details/klinische-studie-zur-sicherheit-und-vertraeglichkeit-des-pruefmedikaments-ale-f02 https://vasas.ch/en/current/studies/studies-details/pet-diagnostic-study https://vasas.ch/en/current/studies/studies-details/takayasuarteritis-clinical-imaging-molecular-and-therapeutic-characteristics-2 https://vasas.ch/en/current/studies/studies-details/clinical-trial-on-the-safety-and-tolerability-of-the-investigational-drug-ale-f02 https://vasas.ch/fr/actuel/l-etude/details-des-etudes/etude-diagnostique-pet https://vasas.ch/fr/actuel/l-etude/details-des-etudes/takayasuarteritis-clinical-imaging-molecular-and-therapeutic-characteristics-3 https://vasas.ch/fr/actuel/l-etude/details-des-etudes/etude-clinique-sur-la-securite-et-la-tolerance-du-medicament-experimental-ale-f02 https://vasas.ch/de/event-details/webinar-der-winter-kommt-alles-rund-ums-impfen https://vasas.ch/de/event-details/4rd-vasas-day-2026-in-aarau https://vasas.ch/de/event-details/webinar-was-kann-gesunde-ernaehrung-bewirken https://vasas.ch/de/event-details/nationaler-takayasu-tag https://vasas.ch/de/event-details/webinar-neues-aus-der-forschung-und-wissenschaft https://vasas.ch/de/event-details/patiententag-in-der-Westschweiz https://vasas.ch/de/event-details/3-dach-anca-vaskulitis-forum-2026 https://vasas.ch/de/event-details/Webinar-Wie-funktioniert-das-Immunsystem-und-was-bei-mir-vielleicht-nicht-korrekt. https://vasas.ch/de/event-details/save-the-date-for-22nd-international-vasculitis-workshop https://vasas.ch/de/event-details/vasas-mitgliederversammlung https://vasas.ch/de/event-details/workshop-riesenzellarteriitis-fuer-fachpersonen https://vasas.ch/de/event-details/Ostschweizer-Vaskulitis-Tag https://vasas.ch/de/event-details/patiententag-in-basel https://vasas.ch/de/event-details/patiententag-in-lausanne https://vasas.ch/de/event-details/3rd-vasas-day-2025 https://vasas.ch/de/event-details/kochevent https://vasas.ch/de/event-details/webinar-schluss-mit-dem-datenchaos-wie-laesst-sich-der-naechste-kontrolltermin-gut-strukturieren https://vasas.ch/de/event-details/interdisziplinaere-diskussion-zu-anca-vaskulitis-und-eosinophilen-erkrankungen https://vasas.ch/de/event-details/webinar-zwischen-schub-und-remission-wie-erkenne-ich-die-zeichen-meiner-vaskulitis https://vasas.ch/de/event-details/workshop-anca-vaskulitis-und-eosinophile-krankheiten https://vasas.ch/de/event-details/mitgliederversammlung https://vasas.ch/de/event-details/1-ostschweizer-vaskulitis-tag https://vasas.ch/de/event-details/patiententag-in-st-gallen https://vasas.ch/de/event-details/vasas-patiententag-fuer-betroffene-und-angehoerige https://vasas.ch/en/event-details/webinar-winter-is-coming-everything-you-need-to-know-about-vaccinations https://vasas.ch/en/event-details/4th-vasas-day-2026-in-aarau https://vasas.ch/en/event-details/webinar-what-can-a-healthy-diet-achieve https://vasas.ch/en/event-details/national-takayasu-day https://vasas.ch/en/event-details/webinar-latest-developments-in-research-and-science https://vasas.ch/en/event-details/patient-day-in-western-Switzerland https://vasas.ch/en/event-details/3rd-dach-anca-vasculitis-forum-2026 https://vasas.ch/en/event-details/Webinar-How-does-the-immune-system-work-and-what-might-be-wrong-with-mine. https://vasas.ch/en/event-details/save-the-date-for-22nd-international-vasculitis-workshop-2 https://vasas.ch/en/event-details/vasas-general-meeting https://vasas.ch/en/event-details/giant-cell-arteritis-workshop-for-professionals https://vasas.ch/en/event-details/2nd-Eastern-Switzerland-Vasculitis-Day-for-professionals https://vasas.ch/en/event-details/Patient-day-in-basel https://vasas.ch/en/event-details/patient-day-in-lausanne https://vasas.ch/en/event-details/3rd-vasas-day-2025-2 https://vasas.ch/en/event-details/cooking-event https://vasas.ch/en/event-details/webinar-putting-an-end-to-data-chaos-how-can-the-next-inspection-date-be-well-structured https://vasas.ch/en/event-details/interdisciplinary-discussion-on-anca-vasculitis-and-eosinophilic-diseases https://vasas.ch/en/event-details/webinar-between-flare-up-and-remission-how-do-i-recognize-the-signs-of-my-vasculitis https://vasas.ch/en/event-details/workshop-anca-vasculitis-and-eosinophilic-diseases https://vasas.ch/en/event-details/general-meeting https://vasas.ch/en/event-details/1st-eastern-switzerland-vasculitis-day https://vasas.ch/en/event-details/patient-day-in-st-gallen https://vasas.ch/en/event-details/vasas-patient-day-for-patients-and-relatives https://vasas.ch/fr/details-de-l-evenement/webinaire-l-hiver-approche-tout-ce-qu-il-faut-savoir-sur-la-vaccination https://vasas.ch/fr/details-de-l-evenement/4e-edition-du-vasas-day-2026-a-aarau https://vasas.ch/fr/details-de-l-evenement/webinaire-les-bienfaits-d-une-alimentation-saine https://vasas.ch/fr/details-de-l-evenement/journee-nationale-takayasu https://vasas.ch/fr/details-de-l-evenement/webinaire-actualites-de-la-recherche-et-de-la-science https://vasas.ch/fr/details-de-l-evenement/Journ%C3%A9e-des-patients-en-Suisse-Romande https://vasas.ch/fr/details-de-l-evenement/3e-dach-forum-sur-la-vasculite-anca-2026 https://vasas.ch/fr/details-de-l-evenement/Webinaire-Comment-fonctionne-le-syst%C3%A8me-immunitaire-et-qu-est-ce-qui-ne-fonctionne-peut-%C3%AAtre-pas-correctement-chez-moi https://vasas.ch/fr/details-de-l-evenement/reservez-la-date-du-22e-atelier-international-sur-la-vascularite https://vasas.ch/fr/details-de-l-evenement/assemblee-generale-vasas https://vasas.ch/fr/details-de-l-evenement/atelier-sur-l-arterite-a-cellules-geantes-pour-les-professionnels-de-la-sante https://vasas.ch/fr/details-de-l-evenement/2e-journee-de-la-vascularite-en-suisse-orientale-pour-les-professionnels https://vasas.ch/fr/details-de-l-evenement/journee-des-patients-a-bale https://vasas.ch/fr/details-de-l-evenement/journee-des-patients-a-lausanne https://vasas.ch/fr/details-de-l-evenement/3e-journee-vasas-2025 https://vasas.ch/fr/details-de-l-evenement/evenement-culinaire https://vasas.ch/fr/details-de-l-evenement/webinar-fini-le-chaos-des-donnees-comment-bien-structurer-le-prochain-rendez-vous-de-controle https://vasas.ch/fr/details-de-l-evenement/discussion-interdisciplinaire-sur-la-vascularite-a-anca-et-les-maladies-a-eosinophiles https://vasas.ch/fr/details-de-l-evenement/webinar-entre-poussee-et-remission-comment-reconnaitre-les-signes-de-ma-vascularite https://vasas.ch/fr/details-de-l-evenement/atelier-sur-la-vascularite-anca-et-les-maladies-a-eosinophiles https://vasas.ch/fr/details-de-l-evenement/assemblee-generale https://vasas.ch/fr/details-de-l-evenement/1ere-journee-de-la-vascularite-en-suisse-orientale https://vasas.ch/fr/details-de-l-evenement/journee-des-patients-a-st-gall https://vasas.ch/fr/details-de-l-evenement/journee-des-patients-vasas-pour-les-personnes-concernees-et-leurs-proches